You have reached an outdated page.
Please visit the Defeat Diabetes Foundation's new Web site at:
http://www.DefeatDiabetes.org
Defeat Diabetes: Jury Finds Rezulin Diabetes Drug Not Liable for Deaths

Home

About Diabetes

Complications

Warning Signs

Screening Test

Donate Now

E-Lerts
Index

Latest News

Diabetes Terms

Health & Fitness

Online Press Center

Meet Mr. Diabetes®

Wake Up And Walk® Tour

Headlines & Stories

About Us - Contact Info

Message Board

Links

 

Jury Finds Rezulin Diabetes Drug Not Liable for Deaths
posted 06/03/04
A jury in Los Angeles on Thursday found that a diabetes drug sold by Warner-Lambert, was not responsible for the deaths or illness of three plaintiffs.

The jury determined that the facts presented in the case did not support the claims that Rezulin caused or contributed to the deaths of two people or the liver disease of a third plaintiff, Pfizer said.

"We maintained from the very beginning that Rezulin did not cause or contribute to the health issues alleged in this case," Pfizer spokesman Bryant Haskins said.

"We made a convincing argument and obviously the jury agreed with us," he added.

The U.S. Food and Drug Administration in 2000 determined that Rezulin was more toxic to the liver than other diabetes drugs. Warner-Lambert, under pressure, voluntarily withdrew the drug from the market in March 2000 after two newer drugs with fewer side effects became available.

The drug, which was approved in 1997 for diabetic patients who were not doing well on insulin therapy, has been linked to dozens of deaths and thousands of liver problems and has been the subject of numerous law suits.

Pfizer, the world's largest drugmaker, in January reached a national agreement to settle or dismiss about 35,000 personal injury cases related to Rezulin. The company set aside $975 million to cover the claims. Some cases, however, remain active.

A West Virginia appeals court last year overturned a lower court ruling that denied class-action status in the case and ordered it returned to trial as a class-action case.

But Pfizer, which acquired Warner-Lambert about three months after Rezulin was pulled from the market, is off the hook at least in the California trial after a unanimous jury decision found the plaintiffs failed to prove their case.

Source: Diabetes In Control.com.

June News Article Index

Free Diabetes E-Lerts™ Newsletter:  Subscribe


   
To Change, Or Even Help Save The Lives Of Millions Of People,
Consider Making a Donation to Defeat Diabetes Foundation - Thank You! 

To be sure and come back to keep up with all the Latest News and important information for diabetics - and to remind yourself to manage and control your diabetes, click the yellow link below to add a small icon of our Defeat Diabetes® "Torch" logo to your desktop.  All you need to do after that is click on the "Torch" to open our website.  Remember, we're here for you!Add Us To Your Desktop! 

                                                                                                               

      We subscribe to the HONcode principles of the HON Foundation. Click to verify.We subscribe to the HONcode principles of the Health On the Net Foundation
Date of last update:  08/06/04
To contact Webmaster: webmaster@defeatdiabetes.org 

Translate this page into Spanish using FreeTranslation.com.

 © Copyright 2001 - 2004, Defeat Diabetes Foundation, Inc., All Rights Reserved